Radius Health Lands $27,650,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6030860e-ad1b-4da4-b26f-44cad1ea04b1&Preview=1 - Date
11/25/2011 - Company Name
Radius Health - Mailing Address
201 Broadway 6th floor Cambridge, MA 02139 - Company Description
Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women’s health. - Website
http://www.radiuspharm.com - Transaction Type
Debt, Venture Equity - Transaction Amount
$27,650,000 - Transaction Round
Undisclosed - Proceeds Purposes
Radius will use the proceeds from the second tranche primarily to continue advancing the ongoing Phase 3 clinical study of BA058 Injection, the company’s novel anabolic (bone-building) drug for the treatment of osteoporosis. - M&A Terms
- Venture Investor
Healthcare Financial Services - Venture Investor
Oxford Finance Corporation - Venture Investor
GE Healthare Financial Services - Venture Investor
Undisclosed
